Dr. Hayes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Dr
B1 Floor Cancer & Geriatrics Ctr Recp C
Ann Arbor, MI 48109Phone+1 734-936-6000- Is this information wrong?
Summary
- Medical Oncologist with focus on Breast Cancer at University of Michigan Rogel Cancer Center
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1979 - 1980
Indiana University School of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1982 - 2023
MI State Medical License 2001 - 2023
DC State Medical License 1996 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 1999 Dec 01
- Aromatase Inhibitor Clinical Trial Start of enrollment: 2005 Jan 01
- A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future Prospects.Andi K Cani, Daniel F Hayes> ;Clinical Chemistry. 2024 Jan 4
- Effects ofandgenotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg, Kathy S Albain, Shaker R Dakhil, Nagendra R Tirumali, Julie R Gralow, G...> ;Pharmacogenomics. 2023 Aug 1
- 2 citationsNovel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.Jennifer K Plichta, Samantha M Thomas, Daniel F Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de Los Santos, Amy M Fowler, Armando E Giuliano, Priyanka S...> ;Journal of Clinical Oncology. 2023 May 10
- Join now to see all
Journal Articles
- An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast CancerRichard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerMatthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine
Other
- Measurement of prognostic factors in breast cancerHayes DF
http://www.uptodate.com/contents/measurement-of-prognostic-factors-in-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-10-18 - HER2 and predicting response to therapy in breast cancerHayes DF, Yamauchi H
http://www.uptodate.com/contents/her2-and-predicting-response-to-therapy-in-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-10-04 - Systemic treatment for metastatic breast cancer: General principlesHayes DF
http://www.uptodate.com/contents/systemic-treatment-for-metastatic-breast-cancer-general-principles
UpToDate, Wolters Kluwer Health - 2012-12-06 - Join now to see all
Press Mentions
ASCO Remembers Saul a. Rosenberg, MD, FASCO, ASCO Past President and Pioneer of Hodgkin Lymphoma TreatmentSeptember 7th, 2022- Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory BoardJune 8th, 2022
- Franco Muggia, a Drug Developer and Former Director of NYU Langone’s Perlmutter Cancer Center, Died Unexpectedly on Sept. 8September 17th, 2021
- Join now to see all
Grant Support
- Effects Of Exemestane Or Letrozole On Surrogate Markers Of ResponseNational Center For Research Resources2007
- Pilot Trial Correlating Metabolic Profile Of Tamoxifen With HOT FlashesNational Center For Research Resources2004–2007
- A Multi-Center Randomized Clinical Trial Correlating The Effects Of 24 Months OfNational Center For Research Resources2006
- Correlative Studies Of Erbb-2/Her2 And P53 In Calgb PRO.National Cancer Institute2003–2005
- Docetaxel (TAXOTERE) &Bcl-2-Antisense OligonucleotideNational Center For Research Resources2000
- Phase 2 Clinical Trials Of Oltipraz In Breast NeoplasiaDivision Of Cancer Prevention And Control1999–2000
- Cancer And Acute Leukemia Group B (CALGB) Inst GrantNational Cancer Institute1998–2000
- Phase II Clinical Trial Of Dehydroepi-AndrosteroneDivision Of Cancer Prevention And Control1999
- Correlative Studies Of Angiogenesis In Breast CancerNational Cancer Institute1996–1997
- Correlative Studies Of Angiogenesis In Breast CancerNational Cancer Institute1994–1996
- Circulating C-NEU Protein In Breast Cancer PatientsNational Cancer Institute1991–1992
- Immunodiagnostic Approaches To Breast CancerNational Cancer Institute1985–1987
Committees
- Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Professional Memberships
- Member
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
